Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3 results about "Pim kinases" patented technology

Pim kinases are constitutively active serine/threonine kinases that promote growth factor-independent proliferation by phosphorylating, and thus inhibiting, a range of cellular proteins. They are serine/threonine kinases that control cell growth, differentiation and apoptosis.

Formulations comprising heterocyclic protein kinase inhibitors

PendingUS20260199334A1Immunologic disordersDisease
Provided is a composition comprising a polyglycolized glyceride and a compound having the following structure (I):or a pharmaceutically acceptable salt thereof. Also provided are crystalline forms of the compound of structure (I), or a pharmaceutically acceptable salt thereof. Methods of making the same, and methods for using the same in the treatment of cancer, autoimmune, inflammatory and other Pim kinase-associated diseases, disorders or conditions are also disclosed.
Owner:SUMITOMO PHARMA AMERICA INC

PIM kinase inhibitor in combination with KRAS inhibitor

PendingUS20260130891A1Organic chemistryAntineoplastic agentsKras mutationOncology
It relates to the combination of PIM kinase inhibitor and a KRAS inhibitor for use in treating cancer, in a subject in need thereof. Also provided are compositions or kits comprising same. Furthermore, it also relates to a PIM kinase inhibitor for use in treating cancer with KRAS mutation in a human subject in need thereof.
Owner:NINGBO NEWBAY TECHNOLOGY DEVELOPMENT CO LTD +1

Pim kinase inhibitors

ActiveCN115991706BOrganic active ingredientsOrganic chemistryDiseaseLymphocytic cell
The application provides a compound with a structure shown in a general formula (I), a deuterium compound, a stereoisomer or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the same and a use thereof. The compound provided by the application has a good PIM kinase inhibition effect, is a novel, high-activity and low-toxicity ideal PIM inhibitor, and can be used for treating and / or preventing diseases such as acute myeloid leukemia, myelofibrosis, chronic lymphocytic leukemia, blood tumors such as gastric cancer and prostate cancer, and solid tumors.
Owner:HANGZHOU BANGSHUN PHARM CO LTD